从感染到治疗:在癌症治疗中利用瘤病毒
相关实验视频
Updated: May 27, 2025

12:08
Ex Vivo Infection of Live Tissue with Oncolytic Viruses
Published on: June 25, 2011
12.6K
Sramona Kar1, Sanjana Mehrotra2, Vijay Kumar Prajapati1
1Department of Biochemistry, University of Delhi South Campus, Benito Juarez Road, Dhaula Kuan, New Delhi, India.
Advances in protein chemistry and structural biology
|February 20, 2025
概括
瘤性病毒 (OV) 免疫疗法为晚期癌症提供了一个有希望的,有针对性的方法,显示出高效率和较少的副作用. 本综述涵盖了OV工程,机制,临床进展,挑战和组合疗法,以改善瘤清除和生存.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 免疫治疗是一种免疫疗法.
背景情况:
- 传统的癌症疗法,如化疗和放射治疗,对于更高度的癌症往往是失败的.
- 瘤病毒 (OVs) 经过工程设计,可以选择性地向和摧毁癌细胞,提供一种新的治疗策略.
- 临床前和临床研究支持OV介导免疫疗法与传统治疗相比的疗效和减少副作用.
研究的目的:
- 审查癌症治疗中使用的瘤解毒病毒 (OV) 的修饰,菌株和机制.
- 讨论OV在临床前和临床试验中的进展,包括案例研究.
- 突出与OVs相关的挑战,如患者的病原体暴露和潜在的免疫召回反应,并探索组合疗法的未来前景.
主要方法:
- 关于型病毒 (OV) 治疗的科学文献的综述.
- 对型病毒的修改和工程策略的分析.
- 检查临床前和临床试验数据,包括案例研究.
- 讨论针对瘤和除瘤的病毒机制.
- 探索挑战和组合治疗方法.
主要成果:
- 瘤病毒 (OV) 在治疗晚期癌症方面表现出高效率和较少的副作用.
- 工程化OV可以选择性地向和根除恶性细胞.
- 案例研究显示,OV疗法的临床前和临床试验进展.
- 挑战包括患者特定的因素,如病原体暴露和潜在的非特异性免疫反应.
- 组合疗法在瘤清除,转移阻断和患者存活方面具有优势.
结论:
- 瘤性病毒 (OV) 免疫疗法是治疗耐火性癌症的有效工具.
- 需要进一步的研究和开发来克服挑战并优化OV治疗.
- 涉及OV的组合策略对改善癌症治疗结果和患者存活率具有重大前景.
相关概念视频
Tumor Immunotherapy
463
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
463
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Cancer Vaccines
325
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
325
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Rous Sarcoma Virus (RSV) and Cancer
4.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
4.9K
Mechanisms of Retrovirus-induced Cancers
5.0K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.0K

